Rabaca, Mary Jane H.

HRN: 19-45-36  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/11/2022
AMPICILLIN 1GM (VIAL)
12/11/2022
12/18/2022
IV
2gm
Q6H
PROM
Waiting Final Action 
12/11/2022
CEFUROXIME 500MG (TAB)
12/13/2022
12/20/2022
PO
1 Cap
BID
S/p Nsvd; Prom X 42 HRS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: